Effects of route of inoculation and viral genetic variation on antibody responses to polyomavirus SV40 in Syrian golden hamsters

Comparative Medicine

Volumn 62, Issue 5, 2012, Pages 400-408

  Swain, Jody L ^a   Sroller, Vojtech ^a,b   Wong, Connie ^a   Zhang, Shaojie ^a   Halvorson, Steven J ^a   Herron, Alan J ^a   Kozinetz, Claudia A ^a   Butel, Janet S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS LARGE T ANTIGEN;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; GENETIC VARIABILITY; HYPOTHESIS; INOCULATION; NONHUMAN; SIMIAN VIRUS 40; STATISTICAL SIGNIFICANCE; SYRIAN HAMSTER; VIRAL GENETICS; VIRUS INFECTION; VIRUS PARTICLE; VIRUS STRAIN;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL, TUMOR; CRICETINAE; DRUG ADMINISTRATION ROUTES; GENETIC VARIATION; MESOCRICETUS; SIMIAN VIRUS 40; STATISTICS, NONPARAMETRIC; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84870943716     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Ahuja D, Sáenz-Robles MT, Pipas JM. 2005. SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 24:7729-7745. (Pubitemid 41670675)
2. Animal Welfare Act as Amended. 2007. 7 USC §2131-2159.
3. Atkin SJL, Griffin BE, Dilworth SM. 2009. Polyoma virus and simian virus 40 as cancer models: history and perspectives. Semin Cancer Biol 19:211-217.
4. +-T-lymphocyte responses. J Virol 78:2247-2254.
5. Butel JS. 2000. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 21:405-426. (Pubitemid 30137926)
6. Butel JS, Jafar S, Wong C, Arrington AS, Opekun AR, Finegold MJ, Adam E. 1999. Evidence of SV40 infections in hospitalized children. Hum Pathol 30:1496-1502. (Pubitemid 30032927)
7. Butel JS, Lednicky JA. 1999. Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst 91:119-134. (Pubitemid 29042689)
8. Butel JS, Ozbun MA. 1994. Viral oncoprotein interactions with cellular proteins: simian virus 40 large T antigen and p53 as models, p 282-309. In: Adolph KW, editor. Methods in molecular genetics, vol 4: molecular virology techniques, part A. San Diego (CA): Academic Press.
9. Butel JS, Tevethia SS, Melnick JL. 1972. Oncogenicity and cell transformation by papovavirus SV40: the role of the viral genome. Adv Cancer Res 15:1-55.
10. Carbone M, Lewis AM Jr, Matthews BJ, Levine AS, Dixon K. 1989. Characterization of hamster tumors induced by simian virus 40 small T deletion mutants as true histiocytic lymphomas. Cancer Res 49:1565-1571. (Pubitemid 19088699)
11. Cicala C, Pompetti F, Carbone M. 1993. SV40 induces mesotheliomas in hamsters. Am J Pathol 142:1524-1533. (Pubitemid 24058139)
12. Diamandopoulos GT. 1972. Leukemia, lymphoma, and osteosarcoma induced in the Syrian golden hamster by simian virus 40. Science 176:173-175.
13. Diamandopoulos GT. 1973. Induction of lymphocytic leukemia, lymphosarcoma, reticulum cell sarcoma, and osteogenic sarcoma in the Syrian golden hamster by oncogenic DNA simian virus 40. J Natl Cancer Inst 50:1347-1365.
14. Dubensky TW, Villarreal LP. 1984. The primary site of replication alters the eventual site of persistent infection by polyomavirus in mice. J Virol 50:541-546. (Pubitemid 14135785)
15. Eddy BE, Borman GS, Grubbs GE, Young RD. 1962. Identification of the oncogenic substance in rhesus monkey cell cultures as simian virus 40. Virology 17:65-75.
16. Foreman ZH, Lednicky JA, Fox GE, Willson RC, White ZS, Halvorson SJ, Wong C, Lewis AM Jr, Butel JS. 2004. Phylogenetic analysis of polyomavirus simian virus 40 from monkeys and humans reveals genetic variation. J Virol 78:9306-9316. (Pubitemid 39096540)
17. Fraumeni JF Jr, Ederer F, Miller RW. 1963. An evaluation of the carcinogenicity of simian virus 40 in man. JAMA 185:713-718.
18. Girardi AJ, Sweet BH, Slotnick VB, Hilleman MR. 1962. Development of tumors in hamsters inoculated in the neonatal period with vacuolating virus, SV40. Proc Soc Exp Biol Med 109:649-660.
19. Gjoerup O, Chang Y. 2010. Update on human polyomaviruses and cancer. Adv Cancer Res 106:1-51.
20. Ilyinskii PO, Daniel MD, Horvath CJ, Desrosiers RC. 1992. Genetic analysis of simian virus 40 from brains and kidneys of macaque monkeys. J Virol 66:6353-6360.
21. Institute for Laboratory Animal Research. 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academies Press.
22. Jahrling PB, Scherer WF. 1973. Growth curves and clearance rates of virulent and benign Venezuelan encephalitis viruses in hamsters. Infect Immun 8:456-462.
23. Javier RT, Butel JS. 2008. The history of tumor virology. Cancer Res 68:7693-7706.
24. + Th1-Th2-type of immune response in murine visceral leishmaniasis. Parasitol Res 103:1413-1419.
25. Kendall LV. 2007. Production of polyclonal antibodies, p 41-72. In: Howard GC, Kaser MR, editors. Making and using antibodies. A practical handbook. Boca Raton (FL): CRC Press.
26. Lednicky JA, Arrington AS, Stewart AR, Dai XM, Wong C, Jafar S, Murphey-Corb M, Butel JS. 1998. Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease. J Virol 72:3980-3990. (Pubitemid 28188701)
27. McNees AL, Vilchez RA, Heard TC, Sroller V, Wong C, Herron AJ, Hamilton MJ, Davis WC, Butel JS. 2009. SV40 lymphomagenesis in Syrian golden hamsters. Virology 384:114-124.
28. Newman JS, Baskin GB, Frisque RJ. 1998. Identification of SV40 in brain, kidney and urine of healthy and SIV-infected rhesus monkeys. J Neurovirol 4:394-406. (Pubitemid 28395720)
29. Patel NC, Halvorson SJ, Sroller V, Arrington AS, Wong C, Smith EO, Vilchez RA, Butel JS. 2009. Viral regulatory region effects on vertical transmission of polyomavirus SV40 in hamsters. Virology 386:94-101.
30. Pipas JM. 2009. SV40: cell transformation and tumorigenesis. Virology 384:294-303.
31. Ramqvist T, Dalianis T. 2009. Murine polyomavirus tumour specific transplantation antigens and viral persistence in relation to the immune response, and tumour development. Semin Cancer Biol 19:236-243.
32. Rapp F, Tevethia SS, Rawls WE, Melnick JL. 1967. Production of antibodies to papovavirus SV40 tumor antigen in African green monkeys. Proc Soc Exp Biol Med 125:794-798.
33. Rizzo P, Di Resta I, Powers A, Ratner H, Carbone M. 1999. Unique strains of SV40 in commercial poliovaccines from 1955 not readily identifiable with current testing for SV40 infection. Cancer Res 59:6103-6108. (Pubitemid 30035628)
34. Simon MA, Ilyinskii PO, Baskin GB, Knight HY, Pauley DR, Lackner AA. 1999. Association of simian virus 40 with a central nervous system lesion distinct from progressive multifocal leukoencephalopathy in macaques with AIDS. Am J Pathol 154:437-446. (Pubitemid 29094094)
35. Sroller V, Vilchez RA, Stewart AR, Wong C, Butel JS. 2008. Influence of the viral regulatory region on tumor induction by simian virus 40 in hamsters. J Virol 82:871-879.
36. Stewart AR, Lednicky JA, Benzick US, Tevethia MJ, Butel JS. 1996. Identification of a variable region at the carboxy terminus of SV40 large T-antigen. Virology 221:355-361. (Pubitemid 26291311)
37. Stewart AR, Lednicky JA, Butel JS. 1998. Sequence analyses of human tumor-associated SV40 DNAs and SV40 viral isolates from monkeys and humans. J Neurovirol 4:182-193. (Pubitemid 28167493)
38. Sweet BH, Hilleman MR. 1960. The vacuolating virus, SV40. Proc Soc Exp Biol Med 105:420-427.
39. Tevethia SS. 1970. Immune response of rabbits to purified papovavirus SV40. J Immunol 104:72-78.
40. Vilchez RA, Brayton CF, Wong C, Zanwar P, Killen DE, Jorgensen JL, Butel JS. 2004. Differential ability of 2 simian virus 40 strains to induce malignancies in weanling hamsters. Virology 330:168-177. (Pubitemid 39446576)
41. Vilchez RA, Madden CR, Kozinetz CA, Halvorson SJ, White ZS, Jorgensen JL, Finch CJ, Butel JS. 2002. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 359:817-823. (Pubitemid 34233750)
42. Vonka V, Zavadova H, Kutinova L, Rezacova D. 1967. Development of antibodies against viral and tumor antigens of papovavirus SV40 in monkeys. Proc Soc Exp Biol Med 125:790-794.